Latest period
$13.3B
YoY change
+4.9%
5Y CAGR
+13.6%
Peak year (FY2025)
$13.7B
Latest annual
$13.7B
Total Assets history chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: $13.7B
Total Assets growth chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: +4.9%
Total Assets history table for Edwards Lifesciences (EW) from 1999 to 2025
| FY2025 | $13.7B | +4.9% | +$642M | ||
| FY2024 | $13.1B | +39.4% | +$3.69B | ||
| FY2023 | $9.36B | +12.9% | +$1.07B | ||
| FY2022 | $8.29B | -2.5% | -$210M | ||
| FY2021 | $8.5B | +17.5% | +$1.27B | ||
| FY2020 | $7.24B | +11.5% | +$749M | ||
| FY2019 | $6.49B | +21.9% | +$1.16B | ||
| FY2018 | $5.32B | -6.5% | -$373M | ||
| FY2017 | $5.7B | +26.3% | +$1.19B | ||
| FY2016 | $4.51B | +11.1% | +$451M | ||
| FY2015 | $4.06B | +15.2% | +$535M | ||
| FY2014 | $3.52B | +29.3% | +$800M | ||
| FY2013 | $2.72B | +22.7% | +$503M | ||
| FY2012 | $2.22B | +12.2% | +$241M | ||
| FY2011 | $1.98B | +12.1% | +$213M | ||
| FY2010 | $1.77B | +9.4% | +$152M | ||
| FY2009 | $1.62B | +15.4% | +$215M | ||
| FY2008 | $1.4B | +4.1% | +$55.1M | ||
| FY2007 | $1.35B | +7.9% | +$98.3M | ||
| FY2006 | $1.25B | +1.4% | +$17.7M | ||
| FY2005 | $1.23B | +10.5% | +$116M | ||
| FY2004 | $1.11B | +1.0% | +$11.3M | ||
| FY2003 | $1.1B | +9.2% | +$93.2M | ||
| FY2002 | $1.01B | +3.6% | +$35.2M | ||
| FY2001 | $973M | -10.6% | -$115M | ||
| FY2000 | $1.09B | -24.3% | -$349M | ||
| FY1999 | $1.44B | — | — |
- FY2025$13.7B+4.9%
- FY2024$13.1B+39.4%
- FY2023$9.36B+12.9%
- FY2022$8.29B-2.5%
- FY2021$8.5B+17.5%
- FY2020$7.24B+11.5%
- FY2019$6.49B+21.9%
- FY2018$5.32B-6.5%
- FY2017$5.7B+26.3%
- FY2016$4.51B+11.1%
- FY2015$4.06B+15.2%
- FY2014$3.52B+29.3%
- FY2013$2.72B+22.7%
- FY2012$2.22B+12.2%
- FY2011$1.98B+12.1%
- FY2010$1.77B+9.4%
- FY2009$1.62B+15.4%
- FY2008$1.4B+4.1%
- FY2007$1.35B+7.9%
- FY2006$1.25B+1.4%
- FY2005$1.23B+10.5%
- FY2004$1.11B+1.0%
- FY2003$1.1B+9.2%
- FY2002$1.01B+3.6%
- FY2001$973M-10.6%
- FY2000$1.09B-24.3%
- FY1999$1.44B—
Total Assets values are taken from Edwards Lifesciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported total assets is $13.3B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Edwards Lifesciences (EW) reported total assets of $13.7B – edged up 4.9% year-over-year.
Through 2020–2025 (5 years), Edwards Lifesciences total assets delivered a +13.6% annualised rate; sustaining 3 straight years of year-over-year growth.
The highest annual total assets of $13.7B was reported in 2025. The lowest in the available history was $973M in 2001.
Edwards Lifesciences Total Assets by Year
Edwards Lifesciences Total Assets 2025: $13.7B
Edwards Lifesciences total assets in 2025 was $13.7B, edged up 4.9% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Total Assets 2024: $13.1B
2024's total assets for Edwards Lifesciences came in at $13.1B, surged 39.4% from 2023.
Edwards Lifesciences Total Assets 2023: $9.36B
Edwards Lifesciences posted total assets of $9.36B in 2023, grew 12.9% from 2022.
Edwards Lifesciences Total Assets 2022: $8.29B
In 2022, Edwards Lifesciences reported total assets of $8.29B, edged down 2.5% below 2021.
Edwards Lifesciences Total Assets 2021: $8.5B
Edwards Lifesciences total assets in 2021 was $8.5B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Total Assets
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on EW
Market Cap — 10 rounds, every one of them EW against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.